Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)
To access this article, please choose from the options below
PII: S0167-8140(06)00484-1
doi:10.1016/j.radonc.2006.09.006
© 2006 Elsevier Ireland Ltd. All rights reserved.
